218 related articles for article (PubMed ID: 32050154)
1. Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
Wang M; Zhang J; Zhao H; Wan D; Jiang Z
Int Immunopharmacol; 2020 Apr; 81():106205. PubMed ID: 32050154
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.
Yuan J; Ren HY; Shi YJ; Liu W
Inflamm Res; 2015 Feb; 64(2):137-44. PubMed ID: 25556580
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.
Cheng J; Zhou Y; Chen B; Wang J; Xia G; Jin N; Ding J; Gao C; Chen G; Miao Y; Li W; Liu Z; Wang X
Int J Nanomedicine; 2011; 6():2183-9. PubMed ID: 22114482
[TBL] [Abstract][Full Text] [Related]
4. CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Tang B; Ren H; Liu H; Shi Y; Liu W; Dong Y; Yin Y; Miao S
Inflamm Res; 2016 Nov; 65(11):917-924. PubMed ID: 27423909
[TBL] [Abstract][Full Text] [Related]
5. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Yan CH; Xu LP; Liu DH; Chen H; Wang Y; Wang JZ; Wang FR; Han W; Liu KY; Huang XJ
Clin Transplant; 2015 Jul; 29(7):594-605. PubMed ID: 25969866
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
Solomon SR; Nakamura R; Read EJ; Leitman SF; Carter C; Childs R; Dunbar CE; Young NS; Barrett AJ
Bone Marrow Transplant; 2003 May; 31(9):783-8. PubMed ID: 12732885
[TBL] [Abstract][Full Text] [Related]
7. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Ross M; Schmidt GM; Niland JC; Amylon MD; Dagis AC; Long GD; Nademanee AP; Negrin RS; O'Donnell MR; Parker PM; Smith EP; Snyder DS; Stein AS; Wong RM; Forman SJ; Blume KG; Chao NJ
Biol Blood Marrow Transplant; 1999; 5(5):285-91. PubMed ID: 10534058
[TBL] [Abstract][Full Text] [Related]
9. Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition.
Zhao Y; Huang J; Li T; Zhang S; Wen C; Wang L
J Cell Mol Med; 2022 Feb; 26(4):1060-1070. PubMed ID: 34984827
[TBL] [Abstract][Full Text] [Related]
10. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
11. Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
Nikoloudis A; Buxhofer-Ausch V; Aichinger C; Binder M; Hasengruber P; Kaynak E; Wipplinger D; Milanov R; Strassl I; Stiefel O; Machherndl-Spandl S; Petzer A; Weltermann A; Clausen J
Cytotherapy; 2024 May; 26(5):490-497. PubMed ID: 38385908
[TBL] [Abstract][Full Text] [Related]
12. Berberine Alleviates Acute Lung Injury in Septic Mice by Modulating Treg/Th17 Homeostasis and Downregulating NF-κB Signaling.
Chen L; Liu X; Wang X; Lu Z; Ye Y
Drug Des Devel Ther; 2023; 17():1139-1151. PubMed ID: 37077411
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Huang H; Zheng W; Lin M; Fu J; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
[TBL] [Abstract][Full Text] [Related]
15. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
[TBL] [Abstract][Full Text] [Related]
16. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
17. Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis.
Xu L; Zheng X; Wang Y; Fan Q; Zhang M; Li R; Ye J; Wu X; Zhao W; Zhang Y
Eur J Pharmacol; 2018 Jan; 819():161-168. PubMed ID: 29191769
[TBL] [Abstract][Full Text] [Related]
18. Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE
Feng M; Zou Z; Zhou X; Hu Y; Ma H; Xiao Y; Li X; Ye X
Int Immunopharmacol; 2017 Feb; 43():195-202. PubMed ID: 28024280
[TBL] [Abstract][Full Text] [Related]
19. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
[TBL] [Abstract][Full Text] [Related]
20. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
